Calcium hydroxylapatite (CaHA) fillers are dermal fillers used for facial contouring, facial rejuvenation and treatment of wrinkles and folds. They provide smooth, natural-looking results by collagen and hyaluronic acid stimulation. CaHA fillers are biocompatible and bioresorbable when injected into the skin, providing aesthetically pleasing facial features with minimal side effects. The global CaHA fillers market is estimated to be valued at US$ 5744.75 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing application of CaHA fillers for aesthetic purposes has been a key trend driving market growth over the past decade. Dermal fillers are increasingly being used by individuals seeking short and long-term solutions for aging signs due to rising consumer standards of beauty. The rising affordability of aesthetic procedures has led to a surge in the number of non-invasive procedures. Moreover, growing social media influence and self-obsession with physical appearance has increased the demand for facial fillers globally. CaHA fillers are preferred over other temporary fillers due to their natural effects and low risk of side effects, thus propelling their demand in the cosmetic industry. Additionally, many key players are focusing on new product launches and geographic expansion to leverage growth opportunities in the market.
Segment Analysis
The global calcium hydroxylapatite (CaHA) fillers market is dominated by the facial wrinkles and lines sub-segment. This sub-segment accounts for around 50% of the total market share as CaHA fillers are widely used in treating shallow to moderately deep wrinkles and ridges present on the face. With increasing awareness about aesthetic treatments and growing obsession with youthful looks, the demand for minimally invasive anti-aging treatments has risen significantly. This has contributed to the large share of the facial wrinkles and lines sub-segment.
Key Takeaways
The Global Calcium Hydroxylapatite (CaHA) Fillers Market Size is expected to witness high growth over the forecast period from 2023-2030.
Regional analysis:
North America holds the major share of around 35% of the total calcium hydroxylapatite fillers market. This is attributable to growing emphasis on aesthetic beauty and rising consumption of minimally invasive aesthetic procedures in countries like the US and Canada. Asia Pacific region is expected to witness fastest growth during the forecast period. Increasing medical tourism along with rising disposable incomes is augmenting the growth of the aesthetic industry in countries like China, India and South Korea.
Key players:
Key players operating in the calcium hydroxylapatite (CaHA) fillers market are Allergan, Inc.,Galderma SA,Merz Pharma GmbH & Co.,KGaA, Suneva Medical Inc.,Specialty European Pharma,Sinclair Pharma,Valeant Pharmaceuticals International Inc.,LifeCell Corporation,Dr. Korman Laboratories Ltd.,ForeverInject International Holdings Co. Limited. Allergan and Galderma collectively hold around 60-65% of the total market share due to their robust product portfolio and strong geographical presence across global markets.
For More Insights, Read: https://www.newswirestats.com/calcium-hydroxylapatite-caha-fillers-market-size-share-and-growth-forecast-2023-2030/
